Home » News
News
December 13, 2016
AMMAN, Dec. 13, 2016
Amman Pharmaceutical Industries is proud to annouce the completion and signing of a long term agreement with its future strategic partners HUONS Korea for an innovative dry eye treatment product which is considered a breakthrough in the ophthalmology world. This product will be available to patients in the MENA region under Amman Pharmaceutical Industries' brand and throughout our distribution networks late 2017.
February 16, 2016
Dry Eye and related irritations is one of the most widely spread problems in the MENA region and API is very proud to introduce a relief for it in the form of Hyaluronic Acid single dose units.
March 3, 2014
Amman Pharmaceutical Industries was honored today by the visit of his Excellency Prof. Nidal Katamine, Minister of Laour & Tourism. His Excellency toured our facilities and commended our operations, our staff, and our high quality manufacturing capabilities.
We thank his Excellency for his attentive visit and words of encouragement that will surely solidify our committment to raise our country's status in the international pharmaceutical arena further into the future.
February 7, 2012
AMMAN // Fadi Al Atrash seemed destined for the pharmaceutical sector from a young age.
After all, his grandfather, father and brother worked in the industry, and when he was just 12, Mr Al Atrash's father launched Amman Pharmaceutical Industries.
The business specialises in producing "niche" medicines, such as eye and nose drops, and started out in 1989 with about 30 employees and just 200,000 Jordanian dinars (Dh1 million) of annual revenue.
Since then the company has grown, along with Jordan...
April 8, 2010
Amman Pharmaceutical Industries , represented by Dr. Fadi Al Atrash was selected as a finalist in the 2010 Ernst & Young Jordan's entrepreneur of the year award program. This program aims at rewarding and acknowledging the achievements of Jordanian entrepreneurs as per the global entrepreneurship criteria of Ernst & Young.